Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-25 @ 8:04 PM
Study NCT ID:
NCT00444535
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2007-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lapatinib and Bevacizumab for Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2008-07-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-06
First Submit QC Date:
None
Study First Post Date:
2007-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-07-09
Results First Submit QC Date:
None
Results First Post Date:
2009-08-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-28
Last Update Post Date:
2021-10-25
Last Update Post Date Type:
ACTUAL